This means that assay-reported phenotypes for a subset of variation at the Kir6.2/SUR1 interface (involving αA/B slide helix, M1, βLM sheets) have greater bearing in Kir6.2-linked diseases (e.g., diabetes mellitus). Here, KCNJ11 is linked to diabetes mellitus.